# Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

> **NCT01819935** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 5271 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** linezolid (Zyvox)
- **DRUG:** vancomycin

## Key facts

- **NCT ID:** NCT01819935
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 5271 (ACTUAL)
- **Last updated:** 2014-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01819935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01819935, "Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01819935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*